.jpg)
Nkarta lays off 3rd of staff, including CFO, to fund autoimmune CAR NK program
Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts cash to its lead CAR NK candidate.
Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts cash to its lead CAR NK candidate.
